Osteoarthritis Trial, Recruiting NCT07023185 Sponsor: Ochsner Health System Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07023185
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 years or older
  • People who are a patient of Dr. Howard Hirsch or Dr. Vinod Dasa and are scheduled for a total knee replacement surgery at Ochsner Kenner
  • People who plan to receive all of their post-surgery physical therapy as an outpatient at OTW Driftwood
  • People who speak English
  • People who have been diagnosed with osteoarthritis (the common "wear and tear" type, not caused by another disease)

Who may not be able to join:

  • People who regularly use opioid (strong prescription painkiller) medications on an ongoing basis
  • People who have used opioid medications at any point in the last 3 months
  • People who score 30 or higher on a pain catastrophizing questionnaire (a tool that measures how someone thinks and feels about pain — confirm with trial site)
  • People diagnosed with an inflammatory joint or autoimmune condition, such as gout, rheumatoid arthritis, or lupus
  • People who will be discharged to a skilled nursing facility after surgery rather than going home
  • People who have a medical condition that causes sensitivity or bad reactions to cold, such as Raynaud's disease
  • People who have significant problems with blood flow in the leg being treated
  • People who currently show signs of vein inflammation, leg ulcers, or skin infection (cellulitis) in the affected area
  • People who have significant risk factors for, or current signs of, blood clots travelling through the body — such as a history of pulmonary embolism, heart attack, atrial fibrillation, stroke, or similar conditions
  • People who have a condition where increasing fluid return through the veins or lymphatic system in the affected limb is not medically advisable — for example, lymphedema following breast cancer, or cancer that has spread to the affected limb
  • People with uncontrolled high blood pressure (as determined by their doctor), heart failure, extremely low blood pressure, or poorly managed heart function
  • People with unstable skin conditions in the affected area, such as severe dermatitis, gangrene, or a recent skin graft
  • People who have recently had toe surgery on the same side as the affected leg
  • People who currently show signs of significant swelling-related conditions in the affected limb, such as deep vein thrombosis, chronic venous insufficiency, acute compartment syndrome, congestive heart failure-related swelling, liver failure, or kidney failure
  • People who have an untreated or unstable bone fracture in the affected area
  • People who currently have any active infection, either in one area of the body or throughout the body
  • People who are not fully alert, or who have diabetes, multiple sclerosis, poor circulation, spinal cord injuries, or rheumatoid arthritis
  • People who have areas of broken, damaged, or at-risk skin in the affected region that could affect how cold is conducted across the skin (such as open wounds, scar tissue, burns, or skin grafts)
  • People with signs or a diagnosis of congestive heart failure
  • People with a pre-existing deep vein thrombosis (a blood clot in a deep vein)
  • People with a history of blood clots forming in deep veins (phlebothrombosis)
  • People with a history of blood clots travelling to the lungs (pulmonary embolism)
  • People with fluid build-up in the lungs (pulmonary edema)
  • People with acute inflammation of the veins (thrombophlebitis)
  • People with poorly managed or severe heart function problems
  • People with arterial regulation problems affecting blood flow (confirm with trial site)
  • People with erysipelas (a type of bacterial skin infection)
  • People with cancer or cancer that has spread to the affected limb
  • People with severely uncontrolled high blood pressure
  • People with acute inflammatory skin diseases or active skin infections
  • People with disease causing blockage of veins or arteries
  • People in medical situations where increasing fluid return through veins or the lymphatic system is not advisable
  • People with poor circulation in the outer parts of the body
  • People with severe hardening of the arteries or any active infection
  • People with known blood disorders that increase the risk of clotting, such as paroxysmal cold hemoglobinuria, cryoglobulinemia, sickle cell disease, or cold agglutinin conditions
  • People whose tissues are inflamed due to a recent injury or a flare-up of a long-term inflammatory condition
  • People with reduced blood flow or nerve function in the affected area, including due to paralysis, multiple surgeries, or diabetes
  • People who have difficulty with thinking, understanding, or communicating in a way that would prevent them from giving accurate and timely feedback during the trial
  • People with a known allergy to cold
  • People with cold agglutinin disorders such as paroxysmal cold hemoglobinuria
  • People with Buerger's disease (a condition affecting blood vessels in the limbs)
  • People with chilblains (painful skin reactions caused by cold exposure)
  • People with cryoglobulinemia (a blood condition triggered by cold)
  • People with sickle cell anaemia
  • People with uncontrolled diabetes (as determined by their doctor)
  • People with a known sensitivity or hypersensitivity to cold
  • People with a history of cold-related injury (such as frostbite)
  • People with severe heart or cardiovascular disease, reduced skin sensation, blood clotting disorders, poor circulation, extreme sensitivity to pain in the limbs, very low blood pressure, reduced skin sensitivity, a history of vein ligation or recent skin grafts, or a tumour of the adrenal gland (pheochromocytoma)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (504) 412-1705

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ochsner Health System
Registry
ClinicalTrials.gov
Start date
15 December 2025
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PROMIS Pain NRS subscale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov